I completely agree. As Ive also mentioned before, as customers pay monthly fees rather than a 1 off lump sum, it means that the growth weve seen in the last 2 quarters is greater than we realise. The next 2-3 quarters should show a relatively stable base with the income from the current clients, and if we have more customers (as expected), then this should significantly be boosting our revenue and cash flow.
On a side note, does anyone have access to the register of top 20 holders that they can share? Im curious to see how many shares the top holders have.
- Forums
- ASX - By Stock
- BIG
- 9 month share price target is +$2.00 share
9 month share price target is +$2.00 share, page-121
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIG (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online